Sunday, December 04, 2022   21:30:38
News and Events
.
.
.
.
.
.

By 18-fold increase in neutralizing antibodies

Razi Cov Pars can be used as a booster dose for all corona vaccines used in the country

.

SAFETY OF RAZI COV PARS VACCINE AGAINST OMICRON/ CLINICAL TRIAL LICENSE FOR 12- TO 18-YEAR-OLDS

Mojtaba Noofeli, Director of the Razi Cov Pars vaccine clinical trial site said: Studies led by WHO are currently underway on the effectiveness of existing vaccines against the new Omicron strain, but the final results have not yet been published.

.
.
.
1234>>>
Related Government Centers
Related international centers
Medical Universities
Other
Our social network